Skip to main content
Equibles

Swiss National Bank

Bank

Position in RPRX — Royalty Pharma plc

CIK 1582202 ZURICH, V8
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$65,029,986
+$7,892,919 QoQ
Shares Held
1,159,800
-2.6% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#52
of 646 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. RPRX ranks #5 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
This page 		1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in RPRX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,029,986 1,159,800
2026-03-31 $57,137,067 1,191,100
2025-12-31 $43,485,456 1,125,400
2025-09-30 $38,568,096 1,093,200
2025-06-30 $40,180,656 1,115,200
2025-03-31 $33,156,563 1,065,100
2024-12-31 $27,451,311 1,076,100
2024-09-30 $32,267,574 1,140,600
2024-06-30 $29,629,332 1,123,600
2024-03-31 $34,530,690 1,137,000
2023-12-31 $33,516,988 1,193,200
2023-09-30 $33,260,070 1,225,500
2023-06-30 $41,815,622 1,360,300
2023-03-31 $50,456,412 1,400,400
2022-12-31 $56,169,776 1,421,300
2022-09-30 $60,640,057 1,509,210
2022-06-30 $63,165,520 1,502,510
2022-03-31 $57,984,557 1,488,310
2021-12-31 $51,745,623 1,298,510
2021-09-30 $25,262,221 699,010
2021-06-30 $29,287,764 714,510
2021-03-31 $29,299,554 671,700
2020-12-31 $21,496,475 429,500